Abstract
Synucleinopathies are neurological diseases that are characterized by the accumulation of aggregates of a cytosolic protein, α-synuclein, at the plasma membrane. Even though the pathological role of the protein is established, the mechanism by which it damages neurons remains unclear due to the difficulty to correctly mimic the plasma membrane in vitro. Using a microfluidic setup in which the composition of the plasma membrane, including the asymmetry of the two leaflets, is recapitulated, we demonstrate a triple action of α-synuclein on the membrane. First, it changes membrane topology by inducing pores of discrete sizes, likely nucleated from membrane-bound proteins and subsequently enlarged by proteins in solution. Second, protein binding to the cytosolic leaflet increases the membrane capacitance by thinning it and/or changing its relative permittivity. Third, α-synuclein insertion inside the membrane hydrophobic core immobilizes the lipids in both leaflets, including the opposing protein-free extracellular one.
Subject terms: Membrane biophysics, Parkinson's disease
Heo and Pincet demonstrate the influence of α-synuclein aggregation on in vitro asymmetric membranes using a microfluidic setup. They show that synuclein aggregation on the asymmetric membranes leads to its thinning and formation of pores of discrete sizes and synuclein insertion immobilizes both the leaflets of the asymmetric membrane.
Introduction
α-synuclein (αSyn) is a cytosolic protein that has been associated for decades with the pathogenesis of neuropathologies known as synucleinopathies, such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy1–4. Native αSyn is an essentially unstructured protein in the cytosol5–7. It is well established that the starting point of αSyn pathological action is its accumulation, probably as α-helices, on negatively charged membranes such as the plasma membrane2,8–13. However, how this accumulation disrupts neuronal function and leads to neuronal death remains largely unclear2,14–18. Recent in vitro studies proposed that αSyn may be able to form pores4,19–24 in membranes which would be lethal to neurons. But applying their hypothesis to physiology may not be appropriate since all the model membranes that were used have a lipid composition very different from that of the plasma membrane. One notable peculiarity of the plasma membrane is that it is very asymmetric: the cytosolic and extracellular leaflets have completely different compositions25–29. Even though this asymmetry is required for physiological membrane processes, it is difficult to reproduce on model membranes.
We recently developed a microfluidic setup allowing the formation of horizontal lipid membranes with a controlled composition of each leaflet30. Furthermore, the electrical and optical properties of the membranes can be simultaneously measured. Hence, this setup is perfectly adapted to test the pore hypothesis on an asymmetric membrane. We find that αSyn induces pores that are more stable with asymmetric membranes than with symmetric membranes. The pores display discrete perimeters that are consistent with the addition of unit-blocks on the latest expanded pore. The unit-block, which is likely to contain either one protein that spans the membrane thickness twice or two proteins, each spanning it once only, increases the perimeter of the pore by 2–3 nm. Varying the αSyn concentration in the cytosolic side, we suggest that the initial pore is nucleated from αSyn bound to the membrane and contains two unit-blocks, and the subsequent unit-blocks seem to come one at a time from the αSyn remaining in solution. We also took advantage of our setup to visualize the membrane and found, using fluorescence recovery after photobleaching (FRAP), that the presence of membrane-bound αSyn reduces the membrane fluidity. Surprisingly, when αSyn is bound to one leaflet, the fluidity of the other leaflet is also impaired. Finally, αSyn increases the overall membrane capacitance. This increase can only be due to a decrease in membrane thickness and/or change in relative permittivity. These results show that binding of αSyn to the membrane simultaneously induces changes in the membrane topology, morphology, and fluidity which prevent normal behavior of neurons and eventually neuronal death.
Results
αSyn disrupts asymmetric membranes
All experiments presented here were performed using a microfluidic setup we recently developed30. In a poly(dimethylsiloxane) (PDMS) chip, two horizontally crossed-channels are vertically separated by a tiny cylindrical hole (Fig. 1a and Methods). The lower channel is directly above a microscope coverslip; the upper one is right above the cylindrical hole. The chip is initially filled with squalene. To form asymmetric membranes having plasma membrane-like composition26, two sets of small unilamellar vesicles (SUVs) were prepared in a 150 mM KCl, 25 mM HEPES, pH 7.4 buffer and flowed in each channel (Fig. 1b). The first (resp. second) set had a lipid composition resembling that of the cytosolic (resp. extracellular) leaflet of the plasma membrane (see Methods for detailed compositions) and was flowed in the upper/cytosolic (resp. lower/extracellular) channel, trapping a 1 nl squalene droplet in the cylindrical hole. The SUVs spontaneously fused with the squalene droplet to form a monolayer at each squalene/buffer interface as previously described30,31. A key to the functionality of this setup is the complete absorption of the squalene droplet by PDMS. During this absorption process, the two monolayers meet and zip over ~30 min to form an oil-free asymmetric membrane30. Membrane formation is simultaneously monitored by bright-field or fluorescence microscopy and capacitance measurements (Fig. 1c, d). Without αSyn, the bilayer is extremely stable for ~3 h after complete zipping. When αSyn was flowed in the cytosolic channel, the membrane became covered with αSyn in a few minutes (Fig. 1e). The accumulation of αSyn was followed by rapid rupture of the membrane (Fig. 1b and f). In the range of concentrations that we tested, 5 nM to 250 nM, the lifetime was reduced to ~15 min on average (Fig. 1g). Hence the presence of αSyn accelerates membrane rupture. Besides, the mean lifetime does not seem to depend on the concentration (Fig. 1g), suggesting that the process of αSyn binding to the membrane is fast enough to be completed much before membrane rupture.
As a comparison, we added αSyn (25 nM) in the extracellular channel and observed that the lifetime was reduced to a lower extent than when αSyn is in the cytosolic channel, ~45 min instead of ~15 min (Supplementary Fig. 1a).
Finally, we tested symmetric membranes with a lipid composition resembling the cytosolic leaflet (see Methods for detailed composition). Titrating αSyn in one channel, the lifetime reduced much less than in the case of the asymmetric membrane: it varied from almost 3 h at 5 nM down to ~30 min at 250 nM (Fig. 1g). We repeated this titration while also having αSyn in the other channel at 60 nM. The result was an additional decrease in the membrane lifetime that became similar to the one observed with the asymmetric membrane when there was 75 nM or more αSyn in the other channel (Supplementary Fig. 1b).
αSyn forms long-lasting pores in asymmetric membranes
It was previously reported that αSyn induces pores, i.e., “holes” in the membrane. To test whether such pores exist with asymmetric membranes and could cause membrane rupture, we performed electrical current measurements. After αSyn was flowed in the cytosolic channel during monolayer zipping, a 100 mV constant voltage was applied between the two channels (Fig. 2a). Two αSyn concentrations were tested, 25 and 250 nM. Initially, no current was detected, showing that there was no aqueous connection between the two sides of the membrane (Fig. 2a–c). About 15 min after flowing the αSyn, an increase in current occurred, indicating the opening of a pore in the membrane. With 250 nM αSyn, the current continued to steadily increase and reached an out of range value within 10 ms. At that point, the membrane was broken, as confirmed by fluorescence (Fig. 1f). When 25 nM αSyn was used, the kinetics of the pore was slower with a step-wise variation of the current. Overall the current was increasing, but it sometimes transiently decreased. As in the 250 nM case, the membrane eventually ruptured after pore opening but the pore lifetime was drastically changed: it lasted longer, between 10 and 30 s. Hence, decreasing 10 times the bulk αSyn concentration did not affect the delay before pore formation but increased the pore lifetime more than 100 times.
The presence of pores was also tested with symmetric membranes at 250 nM αSyn. As expected, pores were observed (Fig. 2d). However, the pore kinetics was strikingly different from that observed with asymmetric membranes. Pores were able to reseal as attested by pore opening followed by the disappearance of any current. This is consistent with previous observations4,19,24. Hence, several pores could sequentially be formed on the same membrane without disrupting it. Some pores opened with a specific current value and resealed without any step-increase in intensity while others displayed a few current step-increases prior to disappearing. The lifetime of these pores was typically 10–100 ms. In some cases, a cascade of transient pores occurred in 100 ms or less. Because of the low probability to form two independent pores in such a short time, we attribute this type of behavior to the same proteins that remain correctly positioned to form a pore, i.e., the same pore cycles between an open and closed conformation (Fig. 2d). Eventually, the membrane broke while a pore was open, typically ~30 min after αSyn was flowed, and ~4 pores were formed during membrane lifetime.
We measured pores with similar kinetics during bilayer zipping and with fully expanded bilayers. This similarity rules out any artifact that may come from the interaction between αSyn, the membrane and the PDMS chip.
The rim of pores is made of unit-blocks with 2 α-helices
For any given current trace, discrete distributions of the current intensity, I, are observed (Fig. 3a and Supplementary Fig. 2). Two non-exclusive processes can be envisioned to explain these discrete distributions: (i) the successive opening and closing of several identical pores, or (ii) the enlargement of a single pore. To differentiate between these two possibilities, we analyzed 193 current jumps between two steps and evaluated the current step intensity value, In, where n is the number of the step. The nth jump, as seen in Supplementary Fig. 2, is In–In–1. If identical pores sequentially opened, I(n) should be a multiple of the intensity of a single pore, I1, and therefore should vary as nI1. This linear variation is not observed experimentally (Fig. 3b), showing that sequential opening of multiple pores is not happening. Thus, the existence of a single pore of various sizes seems more likely. The pore diameter variation supports this hypothesis. Indeed, for a cylindrical pore, I is related to the pore diameter, d, and length, l, through:
1 |
where G is the molar conductivity (~10 S M−1m−1), C the concentration (~150 mM) and U the voltage (100 mV). Using this approximation, the diameter of the nth step, d(n), varies linearly with n (Fig. 3c). Equivalently, the perimeter of the pore, i.e., the length of the rim of the pore, p(n), also varies linearly with n. This linear dependency shows that, for each step, a constant length is added to the perimeter, suggesting that the pore is expanded by inserting a nano-size unit-block of αSyn. This is consistent with another study on symmetric membranes in which three sequential steps were observed24. This unit-block may contain either one protein or several proteins that simultaneously bind at the rim.
Strikingly, the variation of d with n intercepts the x-axis at n = –1 ± 0.5. This indicates that the first step contains 2 unit-blocks. Because the edge of the pore is probably made of α-helices, three or more α-helices must span the membrane to actually have a hole in the center. Since a newly nucleated pore has two unit-blocks, there must be four α-helices or more in the initial pore edge. To estimate the dimension of the unit-block, p/n, from Eq. 2, a value must be chosen to the pore length. It is larger than the membrane thickness, 5 nm. In addition, two α-helices were found in micelle-bound αSyn32. It is difficult to assume that the pore can exceed their length, i.e., ~40 residues or, equivalently, ~10 nm. Assuming the thickness of the pore is 5 nm (resp. 10 nm), the perimeter would increase by 2.2 ± 0.8 nm (resp. 3.1 ± 1 nm) per unit-block (Fig. 3d). The diameter of an α-helix is typically 1.2 nm. Hence, a 2–3 nm increase corresponds to the addition of two α-helices. With this analysis, the initial pore is made of four α-helices and each subsequent step-increase in current corresponds to the addition of two α-helices. Thus, each unit-block contains either one protein spanning twice the membrane or two proteins spanning the membrane once (Fig. 3e).
Finally, because pore formation time seems independent of αSyn concentration, pore nucleation is likely due to proteins that are already membrane-bound. However, the pore kinetics was slower for lower bulk αSyn concentration, indicating that the subsequent unit-blocks come from proteins in solution and not from the membrane. Since oligomeric states of αSyn do not seem to exist in solution33, we favor a model in which αSyn is added one at a time and each protein contributes to two additional α-helices. Then, the initial pore contains two proteins.
There was no quantitative difference between the asymmetric and the symmetric membranes regarding the values of the step-intensities of the current, suggesting the pore structure is independent of the membrane composition.
αSyn increases the membrane capacitance
Binding and accumulation of αSyn on membranes induces pore formation and membrane rupture. Hence, there are strong interactions between αSyn and the lipid in the cytosolic leaflet and likely part of the extracellular leaflet that lead to topological changes. How these interactions affect the lipid arrangement is unclear. To address this question, we have measured the capacitance of the membrane during αSyn binding. In the presence of 100 nM αSyn in the cytosolic channel, the capacitance was 20% larger than without protein after full zipping of the bilayer (Fig. 4a and Supplementary Fig. 3). This was not observed with a control transmembrane protein for which the final capacitance actually decreased (t-SNARE, target membrane-soluble N-ethylmaleimide-sensitive factor attachment protein receptor). The membrane capacitance, Cm, is related to the hydrophobic thickness, e, and area, A, of the bilayer through:
2 |
Thus, an increase in capacitance is likely due to an increase in area, a decrease in thickness or a change in relative permittivity, . Since lipids are incompressible, the total volume of a lipid molecule remains constant which implies that a decrease in membrane thickness is automatically associated with a commensurate increase in membrane area. Hence, the increase in capacitance can only have two non-mutually exclusive origins: simultaneous thinning and area expansion of the membrane and/or increase in relative permittivity. In the first case scenario, a ~20% change in capacitance could correspond to a simultaneous ~10% increase of the membrane area and ~10% decrease of the membrane thickness. This thinning/stretching of the membrane may originate from the insertion of αSyn that force the lipid leaflet to adopt a thinner conformation, at least locally (Fig. 5). A 20% increase in relative permittivity of would be necessary to account for the capacitance increase. However, since thinning/stretching of the membrane by αSyn binding was previously reported34, we favor this explanation without excluding a possible increase in relative permittivity. In any case, to increase the membrane capacitance, αSyn must interact deep inside the hydrophobic core of the membrane which may affect membrane fluidity; this is what we tested next.
αSyn on the cytosolic leaflet freezes the other leaflet
FRAP was used to evaluate the effect of αSyn on the membrane fluidity (Fig. 4b). This was done on symmetric membranes because the working time was too short on asymmetric ones before rupture in the presence of αSyn. As expected, without protein, both leaflets of the membrane were completely fluid (Supplementary Fig. 4)35. Upon adding αSyn in one channel at 100 nM, 50% of the lipids in the cis-leaflet were immobile, confirming the strong interaction between the proteins and the lipids. Surprisingly, the trans-leaflet was also affected: 25% of the lipids in the αSyn-free leaflet were immobile. This shows unambiguously that αSyn penetrates deep inside the membrane and interacts with the trans-lipids, immobilizing 25% of them. When αSyn is added in both channels, 75% of the lipids are immobilized. Using fluorescent αSyn showed that the membrane-bound proteins are completely immobile, as expected36,37. Hence, αSyn binds membrane tightly which freezes the extracellular leaflet.
Discussion
Overall, these results indicate that αSyn takes nanometric control of the membrane topology, morphology and fluidity. We propose a putative molecular model of the in vivo process that leads to neuronal malfunction and eventually cellular death (Fig. 5a, b). Initially, αSyn is monomeric in the cytosol. It quickly binds to the cytosolic leaflet. We cannot differentiate between a lateral loading (αSyn laying flat on the cytosolic leaflet) and longitudinal insertion (αSyn crosses the membrane). However, since αSyn interacts with both leaflets of the membrane, it is likely that a fraction of the αSyn is longitudinally inserted. As a result, αSyn immobilizes a large fraction of the lipids, which induces a defective fluidity that freezes the membrane. Finally, because αSyn penetrates deep inside the membrane, it occasionally achieves a molecular arrangement comprising four α-helices emanating from two proteins that leads to the nucleation of a pore. Once the pore is open, it does not reseal for asymmetric plasma membranes. Then, αSyn molecules from the solution bind at the rim one at a time and enlarge the pore, each protein adding two α-helices to the pore perimeter.
Pore expansion is highly dynamic: αSyn from the solution can bind and unbind. The pores are more stables in the case of physiological membranes compared to symmetric ones. Quantitatively, this difference in stability is due to different binding and unbinding rates, which can be roughly estimated. Typically, a new unit-block is added every 10 ms at 25 nM αSyn with the asymmetric membrane and at 250 nM αSyn with the symmetric membrane. The resulting binding rates are therefore of the order of 4 s−1nM−1 for the asymmetric bilayer and 0.4 s−1nM−1 for the symmetric bilayer. The unbinding rate is about 100 s−1 for both asymmetric and symmetric bilayers. Hence, the corresponding affinity would be ~10 times better for the asymmetric membrane: 25 nM vs. 250 nM. These affinity values were to be expected as long-lasting pores were observed at 25 nM for the asymmetric membrane and 250 nM for the symmetric one. The affinity difference between the two types of membranes is probably due to a lower line tension of the rim. The composition of the asymmetric membrane likely favors high local curvatures and/or a better insertion of the protein because αSyn is sensitive to hydrophobicity, or equivalently, curvature38. This difference is also consistent with the decrease in membrane lifetime (Fig. 1g). The affinity values remain in the range of previously published affinities for the binding of αSyn with membranes, 65 nM39. This quantitative analysis is valid only for the kinetics after pore nucleation and is not valid for the nucleation or complete resealing of the pore which entails a different molecular process.
The physiological consequences of these membrane modifications are dramatic and potentially lethal to the cell (Fig. 5c). A putative decrease in membrane thickness may alter the insertion of some transmembrane proteins because of the mismatch between the hydrophobic core of the bilayer and the length of the transmembrane domain40,41. This mismatch may lead to incorrect folding and functionality of the protein. The reduced fluidity of the membrane prevents protein diffusion and, consequently, most physiological processes that normally occur at the plasma membrane. For instance, it would prevent or slow down the formation of molecular complexes or membrane fusion42–45. Finally, the formation of stable pores disrupts the molecular gradients between the cytosolic and extracellular media46–48. An example is calcium gradient: calcium concentration is actively maintained at a low level in the cytosol (in the 1 µM range or less) and high level outside of the cell (~1 mM). The equilibration between the inner and outer calcium concentration suppresses any evoked-neuronal activity. Also, soluble αSyn could pass through the pore and start accumulating on the extracellular leaflet of the plasma membrane. The presence of extracellular αSyn was actually observed in vivo. It may enhance the immobilization of membrane-bound molecules and facilitate membrane disruption.
Methods
Microfluidic chip fabrication
The bilayer-forming chip was constructed as previously described30. In brief, a Titan2 HR (Kudo3D) 3D-printer was used to provide the two grooves (10 mm × 400 μm × 200 μm and 5 mm × 400 μm × 400 μm, length × width × height) for the channels (upper and lower, respectively) and the cylindrical hole (diameter ~120 μm × length ~100 μm) for the bilayer formation. After assembling the two molds, a 9:1 mixture of Sylgard 184 (Dow Corning) was poured, cured at 72 °C for 50 min, and detached for subsequent curing at 72 °C for 12 h. Additional PDMS cubes, 10 mm × 3 mm × 5 mm (length × width × height) punched with 0.5 mm Biopsy Punch (World Precision Instruments) and 3 mm × 3 mm × 5 mm (length × width × height) PDMS, were glued with PDMS mixture to create top cover and bottom tube holder, respectively. After punching the bottom tube holder with 0.5 mm Biopsy Punch, the lower channel was created by sealing the bottom groove with a Precision Cover Glass #1.5 (Thorlabs) by plasma cleaner (Harrick Plasma). After cleaning with acetone and isopropanol for 5 min with sonication and drying at 24 °C for 2 h, the chips which absorbed the 1 nl trapped oil during bilayer formation in ~1 h were selected for subsequent experiments.
Optical and electrical monitoring of membrane formation
Two lipid monolayers on each side of squalene droplet were separately formed by different SUVs composition: DOPC:DOPS:Cholesterol:DOPE:PIP2 at 7:15:45:30:3% in mol for the monolayer adjacent to cytosolic (upper) channel, DOPC:DOPS:Cholesterol:DOPE:Sphingomyelin at 20:5:45:15:15% in mol for the other adjacent to extracellular (bottom) channel. In the case of symmetric bilayer, the extracellular leaflet had the same composition as the cytosolic one: DOPC:DOPS:Cholesterol:DOPE:PIP2 at 7:15:45:30:3%. The abbreviations of the lipids are: DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; DOPS, 1,2-dioleoyl-sn-glycero-3-phosphoserine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; PIP2, 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate) (ammonium salt).
Typically, the desired composition of dried lipids was rehydrated with bilayer buffer (25 mM HEPES, 150 mM KCl, pH 7.4) to reach a 5 mM final concentration. The mixture was sonicated with the following protocol repeated three times cycles (5 s pulse - 5 s pause) followed by one minute pause at 4 °C. About 2 μl of each SUV solution was aspirated using neMESYS Syringe Pumps (Cetoni) into each cytosolic (top) and extracellular (bottom) channel syringe filled with bilayer buffer. After filling up the chip with squalene, the extracellular syringe was pushed with a constant flow rate at 0.005 μl/s to form an extracellular side monolayer. One minute later, the cytosolic syringe was pushed at 0.01 μl/s. Once the two electrodes at the outlet of each channel were immersed in buffer, the flow rate was decreased and kept at 0.0012 μl/s throughout the experiment.
About 1 h after the two monolayers were formed, the squalene trapped in the cylindrical hole was sufficiently absorbed to sufficiently reduce the inter-leaflet distance for bilayer nucleation at the center of the droplet. Upon additional squalene absorption, the bilayer continued zipping and expanding until it reached the inner surface of the cylindrical hole. Usually, the desired concentration of αSyn was injected at this stage at 0.01 μl/s flow rate. In specific cases (e.g., bilayer area-dependent capacitance measurement), αSyn was injected in before membrane nucleation. The bilayer formation was observed simultaneously with an EPC10 USB amplifier (HEKA) and an Eclipse Ti confocal microscope (Nikon) with add-ons, such as CSU-X spinning disk (Yokogawa), TuCam (Andor), and dual iXon Ultra camera (Andor). In general, bright-field images were recorded in 1 fps during the capacitance measurement with a 10 mV sinusoidal wave and 20 kHz frequency which was generated by the lock-in function in PatchMaster software (HEKA). When bilayer was ruptured by its native lysis tension or presence of αSyn, the capacitance showed unrealistic value.
αSyn pore measurement
The desired concentration of αSyn was injected at 0.01 μl/s flow rate into the cytosolic channel only or both channels (the latter was done in rare cases involving FRAP measurements). To measure ionic current across the membrane, a voltage difference from 0 mV (cytosolic channel) to 100 mV (extracellular channel) was applied to the membrane just after αSyn injection. The αSyn pore formation and enlargement were attested by step-current jumps, and the membrane rupture was measured by infinite current flow (>10 nA). Note that some current measurements showed glitches (<25 pA) regularly (1 s interval in the example presented Fig. 2b). This is due to optical recording because the glitch frequency is always the image acquisition rate and it disappears when there is no image acquisition.
Fluorescence recovery after photobleaching
FRAP experiments were performed with a laser scanning confocal microscope, Leica-SP5. Imaging area, 150 μm × 150 μm, was recorded as 512 × 512 pixels at 0.67 s/frames. Before and after bleaching, the area was illuminated with a 488 nm argon laser at 5% power. During the one-frame bleaching time, laser power was increased to 100% in the region of interest. Emitted light from 520 to 600 nm was collected during the whole process.
Statistics and reproducibility
Each experiment presented has been performed at least three times with a new chip and new lipids. Two separate batches of αSyn (catalog # S7820 from Merck) were used to perform this study. Statistics for the current jumps were obtained on 23, 24, 35, 27, 22, 30, 25 and 7 events for step number 1, 2, 3, 4, 5, 6, 7 and 8 respectively. The significance of error bars, standard error or standard error of the mean, is indicated in each figure legend.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Supplementary information
Acknowledgements
This work was supported by a European Research Council (ERC) funded grant under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 669612) and the French National Research Agency (Grant ANR-14-1CHN-0022-01).
Author contributions
P.H. and F.P. designed the experiments, analyzed the data and wrote the article. P.H. collected the data.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Paul Heo, Email: paul.heo@ens.fr.
Frederic Pincet, Email: frederic.pincet@ens.fr.
Supplementary information
Supplementary information is available for this paper at 10.1038/s42003-020-0883-7.
References
- 1.Schulz-Schaeffer WJ. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia. Acta Neuropathol. 2010;120:131–143. doi: 10.1007/s00401-010-0711-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Auluck PK, Caraveo G, Lindquist S. alpha-Synuclein: membrane interactions and toxicity in Parkinson’s disease. Annu Rev. Cell Dev. Biol. 2010;26:211–233. doi: 10.1146/annurev.cellbio.042308.113313. [DOI] [PubMed] [Google Scholar]
- 3.Poewe W, et al. Parkinson disease. Nat. Rev. Dis. Prim. 2017;3:17013. doi: 10.1038/nrdp.2017.13. [DOI] [PubMed] [Google Scholar]
- 4.Schmidt F, et al. Single-channel electrophysiology reveals a distinct and uniform pore complex formed by alpha-synuclein oligomers in lipid membranes. PLoS ONE. 2012;7:e42545. doi: 10.1371/journal.pone.0042545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT., Jr NACP, a protein implicated in Alzheimer’s disease and learning, is natively unfolded. Biochemistry. 1996;35:13709–13715. doi: 10.1021/bi961799n. [DOI] [PubMed] [Google Scholar]
- 6.Eliezer D, Kutluay E, Bussell R, Jr., Browne G. Conformational properties of alpha-synuclein in its free and lipid-associated states. J. Mol. Biol. 2001;307:1061–1073. doi: 10.1006/jmbi.2001.4538. [DOI] [PubMed] [Google Scholar]
- 7.Mantsyzov AB, et al. A maximum entropy approach to the study of residue-specific backbone angle distributions in alpha-synuclein, an intrinsically disordered protein. Protein Sci. 2014;23:1275–1290. doi: 10.1002/pro.2511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Marques O, Outeiro TF. Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis. 2012;3:e350. doi: 10.1038/cddis.2012.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Davidson WS, Jonas A, Clayton DF, George JM. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 1998;273:9443–9449. doi: 10.1074/jbc.273.16.9443. [DOI] [PubMed] [Google Scholar]
- 10.Perlmutter JD, Braun AR, Sachs JN. Curvature dynamics of alpha-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms. J. Biol. Chem. 2009;284:7177–7189. doi: 10.1074/jbc.M808895200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kamp F, Beyer K. Binding of alpha-synuclein affects the lipid packing in bilayers of small vesicles. J. Biol. Chem. 2006;281:9251–9259. doi: 10.1074/jbc.M512292200. [DOI] [PubMed] [Google Scholar]
- 12.Fortin DL, et al. Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 2004;24:6715–6723. doi: 10.1523/JNEUROSCI.1594-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Jo E, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE. alpha-Synuclein membrane interactions and lipid specificity. J. Biol. Chem. 2000;275:34328–34334. doi: 10.1074/jbc.M004345200. [DOI] [PubMed] [Google Scholar]
- 14.Lorenzen N, Lemminger L, Pedersen JN, Nielsen SB, Otzen DE. The N-terminus of alpha-synuclein is essential for both monomeric and oligomeric interactions with membranes. FEBS Lett. 2014;588:497–502. doi: 10.1016/j.febslet.2013.12.015. [DOI] [PubMed] [Google Scholar]
- 15.Gallegos S, Pacheco C, Peters C, Opazo CM, Aguayo LG. Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson’s disease. Front Neurosci. 2015;9:59. doi: 10.3389/fnins.2015.00059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Grey M, Linse S, Nilsson H, Brundin P, Sparr E. Membrane interaction of alpha-synuclein in different aggregation states. J. Parkinsons Dis. 2011;1:359–371. doi: 10.3233/JPD-2011-11067. [DOI] [PubMed] [Google Scholar]
- 17.Braun AR, Lacy MM, Ducas VC, Rhoades E, Sachs JN. alpha-Synuclein-induced membrane remodeling is driven by binding affinity, partition depth, and interleaflet order asymmetry. J. Am. Chem. Soc. 2014;136:9962–9972. doi: 10.1021/ja5016958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Pfefferkorn CM, Jiang Z, Lee JC. Biophysics of alpha-synuclein membrane interactions. Biochim Biophys. Acta. 2012;1818:162–171. doi: 10.1016/j.bbamem.2011.07.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Quist A, et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl Acad. Sci. USA. 2005;102:10427–10432. doi: 10.1073/pnas.0502066102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Furukawa K, et al. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J. Neurochem. 2006;97:1071–1077. doi: 10.1111/j.1471-4159.2006.03803.x. [DOI] [PubMed] [Google Scholar]
- 21.Kumar R, Kumari R, Kumar S, Jangir DK, Maiti TK. Extracellular alpha-synuclein disrupts membrane nanostructure and promotes S-nitrosylation-induced neuronal cell death. Biomacromolecules. 2018;19:1118–1129. doi: 10.1021/acs.biomac.7b01727. [DOI] [PubMed] [Google Scholar]
- 22.Pacheco C, Aguayo LG, Opazo C. An extracellular mechanism that can explain the neurotoxic effects of alpha-synuclein aggregates in the brain. Front Physiol. 2012;3:297. doi: 10.3389/fphys.2012.00297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Stockl M, Claessens MM, Subramaniam V. Kinetic measurements give new insights into lipid membrane permeabilization by alpha-synuclein oligomers. Mol. Biosyst. 2012;8:338–345. doi: 10.1039/C1MB05293D. [DOI] [PubMed] [Google Scholar]
- 24.Tosatto L, et al. Alpha-synuclein pore forming activity upon membrane association. Biochim Biophys. Acta. 2012;1818:2876–2883. doi: 10.1016/j.bbamem.2012.07.007. [DOI] [PubMed] [Google Scholar]
- 25.Op den Kamp JA. Lipid asymmetry in membranes. Annu Rev. Biochem. 1979;48:47–71. doi: 10.1146/annurev.bi.48.070179.000403. [DOI] [PubMed] [Google Scholar]
- 26.van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 2008;9:112–124. doi: 10.1038/nrm2330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121–1132. doi: 10.1182/blood.V89.4.1121. [DOI] [PubMed] [Google Scholar]
- 28.Comfurius P, et al. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys. Acta. 1990;1026:153–160. doi: 10.1016/0005-2736(90)90058-V. [DOI] [PubMed] [Google Scholar]
- 29.Kosodo Y, et al. Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells. EMBO J. 2004;23:2314–2324. doi: 10.1038/sj.emboj.7600223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Heo P, et al. Highly reproducible physiological asymmetric membrane with freely diffusing embedded proteins in a 3D-printed microfluidic setup. Small. 2019;15:e1900725. doi: 10.1002/smll.201900725. [DOI] [PubMed] [Google Scholar]
- 31.Hwang WL, Chen M, Cronin B, Holden MA, Bayley H. Asymmetric droplet interface bilayers. J. Am. Chem. Soc. 2008;130:5878. doi: 10.1021/ja802089s. [DOI] [PubMed] [Google Scholar]
- 32.Ulmer TS, Bax A, Cole NB, Nussbaum RL. Structure and dynamics of micelle-bound human alpha-synuclein. J. Biol. Chem. 2005;280:9595–9603. doi: 10.1074/jbc.M411805200. [DOI] [PubMed] [Google Scholar]
- 33.Burre J, et al. Properties of native brain alpha-synuclein. Nature. 2013;498:E4–E7. doi: 10.1038/nature12125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Shi Z, Sachs JN, Rhoades E, Baumgart T. Biophysics of alpha-synuclein induced membrane remodelling. Phys. Chem. Chem. Phys. 2015;17:15561–15568. doi: 10.1039/C4CP05883F. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Kahya N, Scherfeld D, Bacia K, Schwille P. Lipid domain formation and dynamics in giant unilamellar vesicles explored by fluorescence correlation spectroscopy. J. Struct. Biol. 2004;147:77–89. doi: 10.1016/j.jsb.2003.09.021. [DOI] [PubMed] [Google Scholar]
- 36.Roberti MJ, Jovin TM, Jares-Erijman E. Confocal fluorescence anisotropy and FRAP imaging of alpha-synuclein amyloid aggregates in living cells. PLoS ONE. 2011;6:e23338. doi: 10.1371/journal.pone.0023338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Spinelli KJ, et al. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson’s disease. J. Neurosci. 2014;34:2037–2050. doi: 10.1523/JNEUROSCI.2581-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Pranke IM, et al. alpha-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J. Cell Biol. 2011;194:89–103. doi: 10.1083/jcb.201011118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Viennet T, et al. Structural insights from lipid-bilayer nanodiscs link alpha-Synuclein membrane-binding modes to amyloid fibril formation. Commun. Biol. 2018;1:44. doi: 10.1038/s42003-018-0049-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Killian JA. Hydrophobic mismatch between proteins and lipids in membranes. Biochim Biophys. Acta. 1998;1376:401–415. doi: 10.1016/S0304-4157(98)00017-3. [DOI] [PubMed] [Google Scholar]
- 41.Fattal DR, Ben-Shaul A. A molecular model for lipid-protein interaction in membranes: the role of hydrophobic mismatch. Biophys. J. 1993;65:1795–1809. doi: 10.1016/S0006-3495(93)81249-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Nemani VM, et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron. 2010;65:66–79. doi: 10.1016/j.neuron.2009.12.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chung CY, Koprich JB, Siddiqi H, Isacson O. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J. Neurosci. 2009;29:3365–3373. doi: 10.1523/JNEUROSCI.5427-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Larsen KE, et al. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 2006;26:11915–11922. doi: 10.1523/JNEUROSCI.3821-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Garcia-Reitbock P, et al. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease. Brain. 2010;133:2032–2044. doi: 10.1093/brain/awq132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Volles MJ, Lansbury PT., Jr. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson’s disease-linked mutations and occurs by a pore-like mechanism. Biochemistry. 2002;41:4595–4602. doi: 10.1021/bi0121353. [DOI] [PubMed] [Google Scholar]
- 47.Danzer KM, et al. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 2007;27:9220–9232. doi: 10.1523/JNEUROSCI.2617-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hettiarachchi NT, et al. alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells. J. Neurochem. 2009;111:1192–1201. doi: 10.1111/j.1471-4159.2009.06411.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.